The last two weeks of 2018 saw 14 novel device or indication approvals in regions around the world, including noteworthy companion diagnostic decisions in Asia, and several important diagnostic or assessment tools granted go-aheads in the US.
One of the most significant of the latest approvals is the Japan Ministry of Health, Labour and Welfare's approval of...






